Extraluminal laser angioplasty (ELAN): a new method for treating atherosclerotic vessels

Fabian Will; Ajoy I. Singh; Wolfgang Ertmer; Herbert Welling; Holger Lubatschowski

doi:10.1117/12.476269

12 September 2003 Extraluminal laser angioplasty (ELAN): a new method for treating atherosclerotic vessels

Fabian Will, Ajoy I. Singh, Wolfgang Ertmer, Herbert Welling, Holger Lubatschowski

Proceedings Volume 4949, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems XIII; (2003) https://doi.org/10.1117/12.476269
Event: Biomedical Optics, 2003, San Jose, CA, United States

Abstract

ELAN is a new method for treating atherosclerotic vessels. Its purpose is to restore wall flexibility by removing arterial wall tissue from the outer arterial layer. This leads to expansion of the narrowed vessel resulting in increased blood flow. We generated cuts in dissected arteries of sheep and pigs by photo-ablation with an ArF-Excimer Laser operating at a wavelength of 193 nm. During the cutting process the vessel diameter was monitored by measuring the running time of the laser induced pressure transients with a pressure transducer lying under the artery. A nearly linear increase of the diameter dependent on the residual wall thickness was found with a maximum increase of vessel diameter about 10%. We also observed that the arterial wall maintains stable to very small residual wall thicknesses i.e. deep cutting. To support the experiments and to test different geometries of tissue removal we performed FEM-Analysis. We simulated vessel deformation and the total strain depending on the depth, width and number of cuts in the outer artieral wall. We also found a significant increase of the "lumen" in a model with atherosclerotic shape obtained from a histological section.

Citation Download Citation

Fabian Will, Ajoy I. Singh, Wolfgang Ertmer, Herbert Welling, and Holger Lubatschowski "Extraluminal laser angioplasty (ELAN): a new method for treating atherosclerotic vessels", Proc. SPIE 4949, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems XIII, (12 September 2003); https://doi.org/10.1117/12.476269

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available